Careology, a HealthTech platform for cancer care has announced that it has raised £1.12m in funding from UK health and technology private angel investors.
Careology claims to be the first intelligent technology helping people with cancer to feel in control of their care.
Its data-driven platform connects users to their family and healthcare provider, helping those affected by a cancer diagnosis to be supported and cared for.
The firm said the funding will be used to expand its team, invest in sales and marketing, and accelerate its technology roadmap.
CEO Paul Landau created the platform after his wife’s diagnosis.
“I am delighted to announce this funding round which will help us accelerate our launch plans, firmly establishing Careology in the market,” he said.
“Careology helps those affected by cancer feel supported and achieve the best possible outcome, with wide ranging benefits for healthcare providers and medical insurance companies.
“Having supported my wife during her cancer journey over the last three years and experienced first-hand the daunting journey faced by patients and their family, I am hugely excited to be delivering a powerful technology platform that transforms cancer care – both during and beyond treatment.”
The firm has also strengthened its board, appointing HealthTech entrepreneur Dr. Henry Carleton as chairman and Alan Marks, former NED of Receipt Bank as investor director.
They join Fergus Kee, chairman of Alina Homecare and former CEO of Bupa Insurance.
“We understand the real need for consumer-centric technology that better supports patients facing such a complex diagnosis,” said Carleton.
“With Careology there is an enormous opportunity to transform the healthcare continuum and we will enable seamless connectivity and insight to clinicians responsible for patient care. Careology is well poised to become the leading global player in this nascent space.”